Aviva Holdings Ltd.
Follow13F filer, CIK 1603935, NEW PROVIDENCE, Bahamas
Aviva Holdings Ltd. reported $143,293,692 across 4 holdings for the quarter ended 2023-03-31, in a 13F-HR filed 2023-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-23-000295
Changes against Q4 2022 are not shown: its report omitted holdings under a confidential treatment request (4 positions on file), so every position would read as new.
- Period
- 2023-03-31
- Reported value
- $143M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q1 2023
Share positions as resolved from 13F-HR 0000895345-23-000295, largest first. % of portfolio is the value over $143,293,692, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC | 3,135,966 | $117M | 81.37% | ||||
| INSEEGO CORPINSEEGO CORP | 20,647,979 | $12M | 8.36% | ||||
| TNGXTANGO THERAPEUTICS INC | 26,961 | $106K | 0.07% | Timeline |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| INSEEGO CORPINSEEGO CORP NOTE 3.250% 5/0 | principal | 24,456,000 | $14.6M |
How Q1 2023 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000895345-23-000295 | base | 2023-05-15 | acceptance time not in the bulk data set |